StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$368.24−4.22 (-1.13%)

Close on Nov 17, 2026Market cap $29.90BP/E 30.2Yield 0.78%

Labcorp revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Labcorp's revenue for the twelve months ending Sep 30, 2026 was $14.59B, up 6.0% year over year. For fiscal 2025 it was $13.95B, up 7.2% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $13.98B in fiscal 2020.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$13.95B+7.2%
FY2024Dec 31, 2024$13.01B+7.0%
FY2023Dec 31, 2023$12.16B+2.5%
FY2022Dec 31, 2022$11.86B-9.7%
FY2021Dec 31, 2021$13.14B-6.0%
FY2020Dec 31, 2020$13.98B+21.0%
FY2019Dec 31, 2019$11.55B+2.0%
FY2018Dec 31, 2018$11.33B+9.9%
FY2017Dec 31, 2017$10.31B+7.9%
FY2016Dec 31, 2016$9.55B+10.1%
FY2015Dec 31, 2015$8.68B+44.4%
FY2014Dec 31, 2014$6.01B+3.5%
FY2013Dec 31, 2013$5.81B+2.4%
FY2012Dec 31, 2012$5.67B+2.3%
FY2011Dec 31, 2011$5.54B+10.8%
FY2010Dec 31, 2010$5.00B+6.6%
FY2009Dec 31, 2009$4.69B+4.2%
FY2008Dec 31, 2008$4.51B+10.7%
FY2007Dec 31, 2007$4.07B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$3.81B+6.9%
Q2 FY2026Jun 30, 2026$3.73B+5.8%
Q1 FY2026Mar 31, 2026$3.54B+5.8%
Q4 FY2025Dec 31, 2025$3.52B+5.6%
Q3 FY2025Sep 30, 2025$3.56B+8.6%
Q2 FY2025Jun 30, 2025$3.53B+9.5%
Q1 FY2025Mar 31, 2025$3.35B+5.3%
Q4 FY2024Dec 31, 2024$3.33B+9.8%
Q3 FY2024Sep 30, 2024$3.28B+7.4%
Q2 FY2024Jun 30, 2024$3.22B+6.2%
Q1 FY2024Mar 31, 2024$3.18B+4.6%
Q4 FY2023Dec 31, 2023$3.03B+3.5%
Q3 FY2023Sep 30, 2023$3.06B+6.6%
Q2 FY2023Jun 30, 2023$3.03B+3.8%
Q1 FY2023Mar 31, 2023$3.04B-22.1%
Q4 FY2022Dec 31, 2022$2.93B+173.5%
Q3 FY2022Sep 30, 2022$2.87B-29.4%
Q2 FY2022Jun 30, 2022$2.92B-23.9%
Q1 FY2022Mar 31, 2022$3.90B-6.3%
Q4 FY2021Dec 31, 2021$1.07B-76.1%
Q3 FY2021Sep 30, 2021$4.06B+4.3%
Q2 FY2021Jun 30, 2021$3.84B+38.7%
Q1 FY2021Mar 31, 2021$4.16B+47.4%
Q4 FY2020Dec 31, 2020$4.49B+52.0%
Q3 FY2020Sep 30, 2020$3.90B+33.0%
Q2 FY2020Jun 30, 2020$2.77B-3.9%
Q1 FY2020Mar 31, 2020$2.82B+1.2%
Q4 FY2019Dec 31, 2019$2.95B+6.0%
Q3 FY2019Sep 30, 2019$2.93B+3.4%
Q2 FY2019Jun 30, 2019$2.88B+0.5%
Q1 FY2019Mar 31, 2019$2.79B-2.0%
Q4 FY2018Dec 31, 2018$2.79B+1.6%
Q3 FY2018Sep 30, 2018$2.83B+8.0%
Q2 FY2018Jun 30, 2018$2.87B+13.4%
Q1 FY2018Mar 31, 2018$2.85B+18.0%
Q4 FY2017Dec 31, 2017$2.74B+15.0%
Q3 FY2017Sep 30, 2017$2.62B–
Q2 FY2017Jun 30, 2017$2.53B–
Q1 FY2017Mar 31, 2017$2.41B–
Q4 FY2016Dec 31, 2016$2.39B–

More Labcorp figures

See a number that looks wrong?